iRadimed IRMD Financing Cash Flow
Financing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by iRadimed in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.
The official record: iRadimed’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →
Ask your AI about iRadimed's financing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is iRadimed's financing cash flow?
- iRadimed (IRMD) reported financing cash flow of -$2.61M in Q1 2026.
- How has iRadimed's financing cash flow changed year-over-year?
- iRadimed's financing cash flow decreased by 14.4% year-over-year, from -$2.28M to -$2.61M.
- What is the long-term trend for iRadimed's financing cash flow?
- Over 4 years (2021 to 2025), iRadimed's financing cash flow has grown at a 418.1% compound annual growth rate (CAGR), from $24.43K to -$17.6M.
- What does financing cash flow mean?
- Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.